AMARIN CORP PLC -ADR (AMRN) Forecast, Price Target & Analyst Ratings
NASDAQ:AMRN • US0231114044
14.18 USD
-0.36 (-2.48%)
Last: Mar 5, 2026, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMARIN CORP PLC -ADR (AMRN).
Forecast Snapshot
Consensus Price Target
$12.24
-13.68% Downside
Next Earnings Forecast
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate$0.00
Revenue Estimate43.291M
ChartMill Buy Consensus
42.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$12.24
Upside
-13.68%
From current price of $14.18 to mean target of $12.24, Based on 7 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
5.88%
Price Target Summary
7 analysts have analysed AMRN and the average price target is 12.24 USD. This implies a price decrease of -13.68% is expected in the next year compared to the current price of 14.18.
The average price target has been revised upward by 5.88% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
42.86%
AMRN was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AMRN.
In the previous month the buy percentage consensus was at a similar level.
AMRN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-06-25 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-04-17 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-11-20 | JP Morgan | Reiterate | Underweight |
| 2023-10-25 | Jefferies | Downgrade | Buy -> Hold |
| 2023-07-20 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-19 | Northland Capital Markets | Maintains | Market Perform -> Market Perform |
| 2023-01-06 | Jefferies | Upgrade | Hold -> Buy |
| 2022-10-19 | SVB Leerink | Maintains | Market Perform |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-05-06 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-05-05 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-02-16 | SVB Leerink | Maintains | Outperform |
| 2022-01-31 | SVB Leerink | Maintains | Outperform |
| 2021-09-09 | SVB Leerink | Initiate | Outperform |
| 2021-05-12 | Goldman Sachs | Downgrade | Neutral -> Sell |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate$0.00
Revenue Estimate43.291M
Revenue Q2Q3.03%
EPS Q2Q100.00%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-7.54%
EPS (1 Month)
N/A
EPS (3 Months)
-100.00%
Next Earnings Summary
AMRN is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is 43.29M USD.
The next earnings revenue estimate has been revised downward by 7.54% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 369.2M -36.69% | 306.911M -16.87% | 228.614M -25.51% | 219.38M -4.04% | 176.97M -19.33% | 173.75M -1.82% | 200.94M 15.65% | 207.88M 3.45% | 741.44M 256.67% | 806.41M 8.76% | |
| EBITDA YoY % growth | -71.2M -363.12% | -14.423M 79.74% | -52.31M -262.68% | -48.977M 6.37% | -18.864M 61.48% | -23.695M -25.61% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -74.3M -407.02% | -17.388M 76.60% | -55.323M -218.17% | -48.981M 11.46% | 5.202M 110.62% | -20.448M -493.08% | 141.88M 793.86% | 222.46M 56.79% | 271.22M 21.92% | 321.4M 18.50% | |
| Operating Margin | -20.12% | -5.67% | -24.20% | -22.33% | 2.94% | -11.77% | 70.61% | 107.01% | 36.58% | 39.86% | |
| EPS YoY % growth | -4.00 -766.67% | -2.80 30.00% | -2.20 21.43% | -0.09 99.55% | -0.02 -104.00% | -0.03 -50.00% | 1.12 3,766.67% | 1.48 31.82% | 0.82 -44.83% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.00 100.00% | 0.00 -100.00% | -0.01 -112.75% |
| Revenue Q2Q % growth | 43.291M 3.03% | 41.805M -42.53% | 39.924M -19.62% |
| EBITDA Q2Q % growth | -4.085M 74.51% | -4.706M -157.16% | -5.541M -980.86% |
| EBIT Q2Q % growth | -4.086M 75.61% | -4.707M -169.49% | -5.543M -226.62% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
385.16%
EPS Next 5 Year
142.35%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-2.88%
Revenue Next 5 Year
27.58%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
18.07%
EBIT Next 5 Year
N/A
AMARIN CORP PLC -ADR / AMRN Forecast FAQ
Can you provide the average price target for AMARIN CORP PLC -ADR stock?
7 analysts have analysed AMRN and the average price target is 12.24 USD. This implies a price decrease of -13.68% is expected in the next year compared to the current price of 14.18.
What is the next earnings date for AMRN stock?
AMARIN CORP PLC -ADR (AMRN) will report earnings on 2026-05-05.
Can you provide the consensus estimates for AMARIN CORP PLC -ADR next earnings?
The consensus EPS estimate for the next earnings of AMARIN CORP PLC -ADR (AMRN) is 0 USD and the consensus revenue estimate is 43.29M USD.
What is the expected long term growth rate for AMARIN CORP PLC -ADR (AMRN)?
The expected long term growth rate for AMARIN CORP PLC -ADR (AMRN) is -2.88%.